New scan aims to spot breast cancer more accurately
NCT ID NCT07180433
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will test a new type of PET/MRI scan that uses a radioactive tracer called 18F-FAPI to see if it can detect breast cancer more accurately than current methods. The researchers will enroll 60 women with breast cancer at various stages. The goal is to see how well this scan finds tumors, lymph node spread, and recurrences compared to standard imaging and lab results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 18F-FAPI (a radioactive tracer)
- What this could lead to
- If successful, this could lead to more precise breast cancer diagnosis, better treatment planning, and less overtreatment.
- What could go wrong
- This is a small, early pilot study (60 participants) testing a new imaging technique. It may not prove better than existing methods, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?